US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 44.220
  • +0.750+1.73%
Close Dec 20 16:00 ET
  • 44.220
  • 0.0000.00%
Post 20:01 ET
4.08BMarket Cap-6.96P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
135.25M
139.49M
+4.25M
Beat Est.
+37.93%
+42.27%
+3.14%
EPS
-1.48
-1.40
+0.08
Beat Est.
+33.46%
+37.22%
+5.65%
Analyst Rating
Strong Buy

Dec 22, 2024

Ultragenyx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 146.336M--
--2024/Q4-- / 143.738M--
Nov 5, 20242024/Q3139.494M / 135.247M--
Aug 1, 20242024/Q2147.026M / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 146.336M--
--2024/Q4-- / 143.738M--
Nov 5, 20242024/Q3139.494M / 135.247M--
Aug 1, 20242024/Q2147.026M / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--

Unlock Free Earnings Estimates

Ultragenyx Pharmaceutical Earnings Reports

  • Ultragenyx Pharmaceutical | 10-Q: Q3 2024 Earnings Report

    Nov 7 02:11

  • Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update

    Nov 6 05:13

  • Ultragenyx Pharmaceutical | 10-Q: Q2 2024 Earnings Report

    Aug 3 03:36

  • Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update

    Aug 2 04:14

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data